ANIK 9.07 ▼ -0.55% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anika Therapeutics Inc.

    NASDAQ: ANIK · Real-Time Price · USD
    9.07
    -0.05 (-0.55%)
    At close: Sep 24, 2025, 3:59 PM
    9.07
    0.00%
    After-hours: Sep 24, 2025, 04:18 PM EDT
    -0.55%
    Bid 9.01
    Market Cap 130.77M
    Revenue (ttm) 123.74M
    Net Income (ttm) -60.63M
    EPS (ttm) -0.9
    PE Ratio (ttm) -10.08
    Forward PE -22.78
    Analyst Buy
    Dividends n/a
    Ask 9.53
    Volume 69,037
    Avg. Volume (20D) 130,485
    Open 9.24
    Previous Close 9.12
    Day's Range 9.02 - 9.28
    52-Week Range 7.87 - 25.65
    Beta 0.63
    Ex-Dividend Date n/a

    About ANIK

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ANIK
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ANIK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Anika Therapeutics Inc. is scheduled to release its earnings on Oct 30, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -27.42%
    Anika Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
    4 months ago
    -21.03%
    Anika Therapeutics shares are trading lower after the company reported mixed Q1 financial results.
    news image

    3 weeks ago · zacks.com

    Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High?

    The consensus price target hints at a 98.6% upside potential for Anika (ANIK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate re...

    news image

    1 month ago · zacks.com

    Anika (ANIK) Upgraded to Buy: Here's What You Should Know

    Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    news image

    1 month ago · seekingalpha.com

    Anika Therapeutics: Undervalued HA Platform With 2027 Catalysts

    Anika Therapeutics is an HA-platform company with regenerative, OA pain, and non-orthopedic products. Their main line is called Integrity. But Hyalofast and Cingal can also eventually target the sizea...

    news image

    1 month ago · seekingalpha.com

    Anika Therapeutics, Inc. (ANIK) Q2 2025 Earnings Call Transcript

    Anika Therapeutics, Inc. (NASDAQ:ANIK ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Cheryl Renee Blanchard - President, CEO & Director Matt Hall - Corporate Particip...

    news image

    1 month ago · zacks.com

    Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates

    Anika Therapeutics (ANIK) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.17 per share a year ago.

    Add to Watchlist